DK127787A - Interleukin-1alfa-derivater og medikamenter indeholdende saadanne derivater - Google Patents

Interleukin-1alfa-derivater og medikamenter indeholdende saadanne derivater

Info

Publication number
DK127787A
DK127787A DK127787A DK127787A DK127787A DK 127787 A DK127787 A DK 127787A DK 127787 A DK127787 A DK 127787A DK 127787 A DK127787 A DK 127787A DK 127787 A DK127787 A DK 127787A
Authority
DK
Denmark
Prior art keywords
derivatives
1alfa
interleukin
medicines containing
medicines
Prior art date
Application number
DK127787A
Other languages
English (en)
Other versions
DK171647B1 (da
DK127787D0 (da
Inventor
Satoru Nakai
Mayumi Kaneta
Yoshikazu Kikumoto
Yeong-Man Hong
Kazuyoshi Kawai
Setsuko Takegata
Kiyoshi Ishii
Yasuo Yanagihara
Yoshikatsu Hirai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK127787D0 publication Critical patent/DK127787D0/da
Publication of DK127787A publication Critical patent/DK127787A/da
Application granted granted Critical
Publication of DK171647B1 publication Critical patent/DK171647B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L5/00—Devices for use where pipes, cables or protective tubing pass through walls or partitions
    • F16L5/02—Sealing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK127787A 1986-03-14 1987-03-12 Polypeptid, der er et interleukin-1 alfa-derivat, gen, der koder for polypeptidet, vektor indeholde nde genet, mikroorganisme indeholdende vektoren, og lægemiddel indeholdende polypeptidet DK171647B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP5788586 1986-03-14
JP5788586 1986-03-14
JP12975986 1986-06-03
JP12975986 1986-06-03
JP14839386 1986-06-25
JP14839386 1986-06-25
JP16025086 1986-07-08
JP16025086 1986-07-08
JP20032386 1986-08-27
JP20032386 1986-08-27

Publications (3)

Publication Number Publication Date
DK127787D0 DK127787D0 (da) 1987-03-12
DK127787A true DK127787A (da) 1987-09-15
DK171647B1 DK171647B1 (da) 1997-03-03

Family

ID=27523408

Family Applications (2)

Application Number Title Priority Date Filing Date
DK127787A DK171647B1 (da) 1986-03-14 1987-03-12 Polypeptid, der er et interleukin-1 alfa-derivat, gen, der koder for polypeptidet, vektor indeholde nde genet, mikroorganisme indeholdende vektoren, og lægemiddel indeholdende polypeptidet
DK051493A DK172339B1 (da) 1986-03-14 1993-05-05 Anvendelse af IL-1alfa eller derivat deraf til fremstilling af et lægemiddel til fremme af CSF-produktion eller til helbredelse af en malign tumor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK051493A DK172339B1 (da) 1986-03-14 1993-05-05 Anvendelse af IL-1alfa eller derivat deraf til fremstilling af et lægemiddel til fremme af CSF-produktion eller til helbredelse af en malign tumor

Country Status (8)

Country Link
US (5) US5008374A (da)
EP (2) EP0578278A1 (da)
JP (1) JP2572220B2 (da)
KR (1) KR950000886B1 (da)
DE (1) DE3750432T2 (da)
DK (2) DK171647B1 (da)
ES (1) ES2009216A6 (da)
HK (1) HK1003115A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
US5290917A (en) * 1988-02-03 1994-03-01 Dainippon Pharmaceutical Co., Ltd. Modified polypeptides of IL-1α
JP2698976B2 (ja) * 1988-02-03 1998-01-19 大日本製薬株式会社 新規ポリペプチド及びそれをコードするｄｎａ
US20030232010A2 (en) * 1988-03-29 2003-12-18 Immunomedics, Inc. Improved cytotoxic therapy
CA1329119C (en) * 1988-03-29 1994-05-03 Milton David Goldenberg Cytotoxic therapy
DK172424B1 (da) * 1988-07-29 1998-06-08 Otsuka Pharma Co Ltd IL-1alfa-Derivater, farmaceutisk præparat omfattende sådanne derivater, anvendelse af IL-1alfa-derivater, DNA sekvenser kod
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
EP0460052B1 (en) * 1989-02-27 1998-04-15 New England Medical Center Il-1 biological activity inhibitors
GB8915414D0 (en) * 1989-07-05 1989-08-23 Ciba Geigy Novel cytokines
US5723117A (en) * 1990-08-10 1998-03-03 Otsuka Pharmaceutical Co., Ltd. Use of interleukin-1 (IL-1) to inhibit development of hepatitis
KR920702230A (ko) * 1990-08-10 1992-09-03 오쯔까 아끼히꼬 간염예방·치료제
JP2818834B2 (ja) * 1991-08-12 1998-10-30 大塚製薬株式会社 ＩＬ−１α安定化医薬製剤
JPH06196070A (ja) * 1992-12-24 1994-07-15 Nec Corp 電磁継電器
US5866134A (en) * 1995-03-24 1999-02-02 Schering Corporation Method for enhancing the antibody response to specific antigens with Interleukin-10
US5753218A (en) * 1996-05-03 1998-05-19 Schering Corporation Method for treating inflammation
US6191269B1 (en) 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
WO1999037321A1 (fr) * 1998-01-22 1999-07-29 Gosudarstvenny Nauchno-Issledovatelsky Institut Osobo Chistykh Biopreparatov (Gosnii Ochb) Preparation immuno-modulatrice a base d'interleukine 1 et procede de preparation
US20030154504A1 (en) * 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
AU2002248192A1 (en) * 2000-12-15 2002-08-12 Stratagene Room temperature stable competent cells
US6855554B2 (en) * 2001-09-21 2005-02-15 Board Of Regents, The University Of Texas Systems Methods and compositions for detection of breast cancer
WO2003044485A2 (en) * 2001-11-20 2003-05-30 Proteex, Inc. Proteonomic methods for diagnosis and monitoring of breast cancer
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568640A (en) * 1981-05-11 1986-02-04 Harvey Rubin Method of inserting amino acid analogs into proteins
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4512974A (en) * 1982-12-08 1985-04-23 Moldawer Lyle L Treatment of protein malnourished surgical patients
US4542017A (en) * 1982-12-09 1985-09-17 Moldawer Lyle L Treatment of protein malnourished bacterially infected humans with LEM
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
JPS60149386A (ja) * 1984-01-17 1985-08-06 Dainippon Pharmaceut Co Ltd インタ−ロイキン１をコ−ドする伝令リボ核酸及びその調製法
EP0155433A1 (en) * 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
DE3587669T2 (de) * 1984-05-18 1994-03-31 New England Medical Center Inc Menschliche IL-1-cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren.
US4762914A (en) * 1984-05-18 1988-08-09 Auron Philip E Truncated protein of interleukin-1
CA1341433C (en) * 1984-06-19 2003-06-24 Douglas P. Cerretti Purification of interleukin 1
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
IT1188550B (it) * 1986-02-07 1988-01-14 Sclavo Spa Peptide sintetico ad attivita' interleukina 1 umana
US4770781A (en) * 1986-03-03 1988-09-13 Merck & Co., Inc. Purification of human interleukin-1 species
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha
US5047505A (en) * 1987-01-27 1991-09-10 Du Pont Merck Pharmaceutical Company High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
US5211946A (en) * 1991-09-13 1993-05-18 Mycogen Corporation Bacillus thuringiensis isolates for controlling acarides

Also Published As

Publication number Publication date
EP0237073A3 (en) 1989-11-15
JP2572220B2 (ja) 1997-01-16
KR870009023A (ko) 1987-10-22
DK51493A (da) 1993-05-05
DK51493D0 (da) 1993-05-05
ES2009216A6 (es) 1989-09-16
US5342615A (en) 1994-08-30
US5371204A (en) 1994-12-06
EP0578278A1 (en) 1994-01-12
US5543140A (en) 1996-08-06
DK171647B1 (da) 1997-03-03
DK127787D0 (da) 1987-03-12
HK1003115A1 (en) 1998-10-09
DK172339B1 (da) 1998-04-06
DE3750432T2 (de) 1995-04-20
JPS63164899A (ja) 1988-07-08
US5008374A (en) 1991-04-16
DE3750432D1 (de) 1994-10-06
KR950000886B1 (ko) 1995-02-03
US5702698A (en) 1997-12-30
EP0237073A2 (en) 1987-09-16
EP0237073B1 (en) 1994-08-31

Similar Documents

Publication Publication Date Title
DK127787D0 (da) Interleukin-1alfa-derivater og medikamenter indeholdende saadanne derivater
DK330287D0 (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK330087A (da) Solfilter-forbindelse og sammensaetning indeholdende samme
DK163923C (da) 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser
DK127887D0 (da) Interleukin-1beta-derivater og medikamenter indeholdende saadanne derivater
DK162888C (da) Ethylendiaminmonoamid-derivater og laegemidler indeholdende disse
DK254488D0 (da) Azaindol- og indolizinderivater
DK497685A (da) Ketongruppeholdige oxindol-3-carboxamid-derivater og laegemiddel indeholdende saadanne derivater
DK272486A (da) Tienopyridoner og farmaceutiske praeparater indeholdende dem
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK617487A (da) Pyrrolderivater og deoxyanaloge deraf
DK272386A (da) Quinoloner og farmaceutiske praeparater indeholdende dem
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK413187D0 (da) Semicarbazoner og thiosemicarbazoner
DK269289D0 (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK590987D0 (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid
DK191787A (da) Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
NO175630C (no) Legemiddelpakning og kombinasjonspakning
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
DK60187A (da) Bis-diozopiperazin-derivater og laegemiddelformuleringer indeholdende saadanne forbindelser
DK488688D0 (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK151785D0 (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
DK197085D0 (da) Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK324187D0 (da) Herbicidt praeparat indeholdende ureaderivater og en modgift
DK619589A (da) Sphingenin og derivater heraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed